Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025CancersOpen Access

Clinical Outcomes and Safety of Ultra-Low-Dose Radiotherapy for Ocular Adnexal Lymphoma: A Systematic Review

View Full Paper
Ask AI
Bookmark
Share

Authors

MGMiloš GrujićSVStanislav VolchenkovAAAidos Akhmetali

Discussion

Loading...

Member takes

Overview

Systematic review analyzes clinical outcomes and safety of ultra-low-dose radiotherapy in ocular adnexal lymphoma, highlighting effective treatment and low toxicity.

Key Points

  • Ultra-low-dose radiotherapy achieved a response rate of 88% to 100% for ocular adnexal lymphoma.
  • Local control rates for ultra-low-dose radiotherapy varied between 63% and 100%, demonstrating its effectiveness.
  • Most studies reported a progression-free survival exceeding 85% at two years, suggesting sustained efficacy.
  • No severe toxicities (grade ≥ 3) were observed, with common acute toxicities being mild and manageable.

Cite This Study

Grujić et al. (2025) studied this question.

synapsesocial.com/papers/68c1d98f54b1d3bfb60fb657https://doi.org/10.3390/cancers17172845
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Ultra low-dose radiation for extranodal marginal zone lymphoma of the lung2024 · 1 citations
  2. 2Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma2024 · 10 citations
  3. 3Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries2024 · 26,093 citations
  4. 4Localized Mucosa-Associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy Has Excellent Clinical Outcome2003 · 386 citations
  5. 5Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?2021 · 43 citations